arrow
N

Niven R. Narain

bpgbio
H指数:32
被引数:4,383

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

BPM31510 Increases the CoQ Pool in Chemically Induced CoQ-Deficient Cells, CoQ-Deficient Patient Fibroblasts, and in Metabolically Active Murine Tissues

BPM31510 在化学诱导的CoQ缺乏细胞、CoQ缺乏患者成纤维细胞以及代谢活跃的小鼠组织中增加CoQ池

2026-04-030
OA
Author Correction: The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue

作者更正:冷诱导的脂酮酸12,13-diHOME促进脂肪酸转运进入棕色脂肪组织

2026-01-020
PRE
Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients

Ia/b期多中心研究:BPM31510IV单药治疗和联合化疗在实体瘤患者中靶向线粒体代谢/瓦伯格效应的应用

2025-12-010
OA
12-Lipoxygenase Regulates Cold Adaptation and Glucose Metabolism by Producing the Omega-3 Lipid 12-HEPE from Brown Fat

12-脂氧合酶通过从棕色脂肪产生ω-3脂质12-HEPE来调节冷适应和葡萄糖代谢

2025-11-050
PRE
BPM31510 engagement of the Warburg effect in GBM to therapeutically modulate tumor metabolism through ROS mediated processes preclinically and clinically

BPM31510通过Warburg效应在GBM中的参与,以在临床前和临床阶段通过ROS介导的过程治疗性调控肿瘤代谢。

2025-11-010
OAAI
Trial in Progress (TiP): Interim analysis of a Phase 2 study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with Vitamin K in combination with Standard of Care (SOC) RT and TMZ in Glioblastoma Multiforme (GBM) patients without prior therapy

进行中试验(TiP):一项关于BPM31510(氧化辅酶Q10的脂质纳米分散体)联合维生素K,与标准护理(SOC)放疗(RT)和替莫唑胺(TMZ)联用治疗未经前期治疗的胶质母细胞瘤(GBM)患者的II期研究的期中分析

2025-11-010
OAAI
A study of RNA splicing and protein expression in the living human brain

对活体人脑中RNA剪接和蛋白质表达的研究

2025-10-090
PRE
A phase II study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with vitamin K in combination with standard of care (SOC) RT and TMZ in glioblastoma multiforme (GBM) patients without prior therapy

一项关于BPM31510(氧化辅酶Q10的脂质纳米分散体)联合维生素K,与标准护理(SOC)放疗(RT)和替莫唑胺(TMZ)联用治疗未经先前治疗的胶质母细胞瘤(GBM)患者的II期研究

2024-09-010
PRE
Identification and validation of N-acetylputrescine in combination with non-canonical clinical features as a Parkinson's disease biomarker panel
2024-05-022
OAAI
Diagnostic assessment of Filamin A ( FLNA) as a serum biomarker for identification of benign prostatic hyperplasia vs aggressive prostate cancer in a prospective Mexican cohort
2024-03-220
PRE
Residual Complex I activity and amphidirectional Complex II operation support glutamate catabolism through mtSLP in anoxia
2024-01-196
OAAI